Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCORD 12: Capecitabine + RT vs Capecitabine + Oxaliplatin + RT in Rectal Cancer
NCT00227747Phase 3Completed
- Sponsor
- Unicancer
- Start
- Nov 2005
- Primary completion
- Oct 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in rectal cancer, sponsored by Unicancer. Started Nov 2005; status: completed.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00227747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227747.